Rivaroxaban Dosing and Administration

Dose-Specific Administration Requirements

The American College of Cardiology recommends that higher doses of rivaroxaban (15 mg and 20 mg) must be taken with food, specifically with the evening meal, to ensure adequate absorption 1

The American College of Cardiology recommends a standard dose of 20 mg once daily with the evening meal for patients with normal renal function (CrCl >50 mL/min) 1, 2
For patients with moderate renal impairment (CrCl 30-49 mL/min), the recommended dose is 15 mg once daily with the evening meal 1, 2, 3
The European Heart Journal guidelines suggest that rivaroxaban is generally not recommended in severe renal impairment (CrCl 15-30 mL/min) 3
Rivaroxaban is not recommended in patients on dialysis or with CrCl <15 mL/min due to lack of clinical trial evidence 2

The time to peak plasma concentration of rivaroxaban is 2-4 hours after ingestion 3
The half-life of rivaroxaban is 5-13 hours 1, 3
Therapeutic anticoagulation is restored within 3 hours of taking a dose of rivaroxaban 4
The bioavailability of rivaroxaban is 66% fasting and 80-100% with food 3

The American College of Cardiology recommends assessing renal function before initiating rivaroxaban therapy 1

The American College of Cardiology recommends avoiding concomitant use of rivaroxaban with combined P-glycoprotein and strong CYP3A4 inhibitors (e.g., ketoconazole) in patients with CrCl 15-80 mL/min 1
The American College of Cardiology also recommends avoiding P-glycoprotein/CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin, St. John's wort) when taking rivaroxaban 1

The American College of Cardiology recommends that Rivaroxaban 15 mg and 20 mg doses should be taken with the evening meal to ensure adequate absorption, while lower doses (2.5 mg and 10 mg) can be taken with or without food 5, 6, 7, 8, 9
Higher doses (15 mg and 20 mg) of Rivaroxaban must be taken with food, preferably with the evening meal, to ensure adequate absorption 5, 7, 8

The American Heart Association notes that potential drug interactions with P-glycoprotein and CYP3A4 inducers or inhibitors can affect rivaroxaban levels 10, 11

Food increases rivaroxaban absorption by 28% (AUC) and 41% (Cmax) for higher doses, and taking with food reduces interindividual variability in drug levels, according to the American College of Chest Physicians 12, 13
The combination of NSAIDs and antiplatelet agents with rivaroxaban increases bleeding time, with a 1.96 times baseline increase with aspirin plus rivaroxaban, and does not affect rivaroxaban pharmacokinetics but increases bleeding risk, as reported by the American College of Chest Physicians 12, 13

Food delays but enhances absorption, with a median time to peak concentration increasing from 2.75 hours (fasting) to 4.0 hours (fed state), which is attributed to prolonged gastric residence time related to rivaroxaban's lipophilicity and limited aqueous solubility, according to the American College of Chest Physicians 12, 13